{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:13:04Z","timestamp":1789884784407,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"French Association of Urology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejca.2018.12.010","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T23:34:47Z","timestamp":1547508887000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-4821","authenticated-orcid":false,"given":"Mathieu","family":"Rouanne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Betari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam\u00e9lia","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00efcha","family":"Goubar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Signolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2018.12.010_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.07.013","article-title":"SnapShot: bladder cancer","volume":"34","author":"Hurst","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.010_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.010_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Gu\u00e9rin: results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ejca.2018.12.010_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1464-410X.2010.09572.x","article-title":"Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Gu\u00e9rin treatment","volume":"107","author":"Kakiashvili","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.ejca.2018.12.010_bib5","article-title":"Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors","author":"Tan","year":"2018","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.ejca.2018.12.010_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2018.12.010_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdw623","article-title":"The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast","volume":"28","author":"Pruneri","year":"2017","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2018.12.010_bib8","first-page":"311","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat\u00a0Pathol"},{"key":"10.1016\/j.ejca.2018.12.010_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ctrv.2016.12.004","article-title":"The immune infiltrate in prostate, bladder and testicular tumors: an old friend for new challenges","volume":"53","author":"Solinas","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ejca.2018.12.010_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ejca.2018.12.010_bib11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2018.12.010_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2018.12.010_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Canc"},{"issue":"17","key":"10.1016\/j.ejca.2018.12.010_bib14","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","article-title":"Prognostic and predictive impact of intra- and peritumoral immune infiltrates","volume":"71","author":"Fridman","year":"2011","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.ejca.2018.12.010_bib15","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin Canc Res"},{"issue":"12","key":"10.1016\/j.ejca.2018.12.010_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1049804","article-title":"Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)","volume":"4","author":"Becht","year":"2015","journal-title":"OncoImmunology"},{"issue":"17","key":"10.1016\/j.ejca.2018.12.010_bib17","first-page":"30151","article-title":"PD-L1 expression and CD8+ T-cell infiltrate are associated with clinical progression in\u00a0patients with node-positive prostate cancer","author":"Petitprez","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"10","key":"10.1016\/j.ejca.2018.12.010_bib18","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"Sharma","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ejca.2018.12.010_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2015.02.021","article-title":"A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma","volume":"68","author":"Patschan","year":"2015","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2018.12.010_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2015.02.2941","article-title":"CD103+ tumor infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder","volume":"194","author":"Wang","year":"2015","journal-title":"J Urol"},{"issue":"6024","key":"10.1016\/j.ejca.2018.12.010_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejca.2018.12.010_bib22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","article-title":"Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of\u00a0response to bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"55","author":"Ayari","year":"2009","journal-title":"Eur Urol"},{"issue":"26","key":"10.1016\/j.ejca.2018.12.010_bib23","doi-asserted-by":"crossref","first-page":"39916","DOI":"10.18632\/oncotarget.9537","article-title":"Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Gu\u00e9rin therapy in bladder cancer","volume":"7","author":"Pichler","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejca.2018.12.010_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","volume":"66","author":"Pichler","year":"2017","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.ejca.2018.12.010_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2017.10.041","article-title":"Immunotherapy with checkpoint blockade in the treatment of urothelial carcinoma","volume":"199","author":"Siefker-Radtke","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.ejca.2018.12.010_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-018-2332-5","article-title":"Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways","author":"Rouanne","year":"2018","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.ejca.2018.12.010_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00262-017-2093-9","article-title":"High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients","volume":"67","author":"Breyer","year":"2018","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.ejca.2018.12.010_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.juro.2017.04.102","article-title":"Differential expression of PD-L1 in high grade T1 vs muscle invasive bladder carcinoma and its prognostic implications","volume":"198","author":"Wankowicz","year":"2017","journal-title":"J Urol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918315569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918315569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:23:07Z","timestamp":1760732587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918315569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"alternative-id":["S0959804918315569"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.010","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}